Abbott Laboratories said its fourth-quarter profit rose 12.3 percent to $1.62 billion, or $1.45 per diluted share, beating Wall Street’s estimates.
Revenue in the quarter was $10.38 billion, up 4.1 percent from $9.97 billion in the same quarter a year earlier.
Analysts polled by Thomson Reuters expected earnings per share of $1.44 per quarter.
